The life sciences, healthcare, and digital health practice at Machado Meyer Sendacz e Opice Advogados advises clients across the pharmaceutical, medical device, biotechnology, veterinary, and agricultural sectors on regulatory compliance with ANVISA and other regulatory authorities. The team also assists life sciences clients with technology transfers, licensing, and M&A transactions. Practice head Renata Rothbarth is widely recognised for her expertise in digital health, telemedicine, and health data privacy matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The firm stands out in the national legal scene for its technical excellence, fast delivery and strategic stance when faced with clients’ challenges. It is a highly qualified team, recognised for its ability to combine in-depth legal knowledge with a practical understanding of the business, which results in effective, tailored solutions while adding high value. Machado Meyer Sendacz e Opice Advogados is, without a doubt, a solid reference — not only for its technical expertise, but for the ethical, strategic and innovative stance it takes in each action.’
‘I would like to highlight Renata Rothbart, who is a reference in her field. She is an exemplary professional, with in-depth legal knowledge, impeccable ethical conduct and an admirable commitment to technical excellence and client results. What sets her apart from other professionals in the market is her rare combination of technical solidity, strategic vision and sensitivity to the real challenges faced by companies.’
‘Machado Meyer Sendacz e Opice Advogados stands as a singular jewel in the national legal landscape, acclaimed for its unwavering devotion to excellence and personalised service. Each client is met with a unique and tailored approach, ensuring that their specific needs are met effectively and innovatively. The team is comprised of exceptionally qualified professionals whose diverse specialisations enable the firm to navigate complex legal issues with mastery.’
‘Renata Rothbarth shines as a beacon of excellence in the Brazilian legal arena, especially in the life sciences area, where her reputation is unmatched. Combining deep technical knowledge with a keen strategic instinct, Renata stands out not only for her impeccable legal skills but also for her ability to navigate complex and ever-evolving terrain. She is not just a lawyer; she is a leader and innovator, always at the forefront of the industry’s most challenging and influential discussions.'
Key clients
- Serum Institute of India Private Limited
- Zalika Farmacêutica Ltda.
- Interfarma da Indústria Farmacêutica de Pesquisa
- Fresenius Kabi Brasil Ltda.
- Neuraxpharm Brasil Importação e Distribuição de Medicamentos Ltda.
- Medsystems Comércio, Importação e Exportação Ltda
- MindCheck
- Agrogalaxy Participações S.A.
- Cimed Indústria Farmacêutica Ltda
Work highlights
Advised Serum Institute of India Private Limited in partnership with Zalika on challenges and negotiations related to a public bidding process by the Ministry of Health for the supply of 57 million Covid-19 vaccine doses.
Advised Interfarma da Indústria Farmacêutica de Pesquisa on regulatory matters involving health innovation, clinical research, and HTA in Brazil.
Assisted SkinCheck with establishing a subsidiary in Brazil and ensuring compliance with local regulations.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Renata Rothbarth
Other key lawyers
Giovanna Pasquini Malfatti